Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).
Marcus J DrakeLuke CanhamNikki CotterillDebbie DelgadoJenny HomewoodKirsty InglisLyndsey JohnsonMary C KisangaDenise OwenPaul WhiteDavid CottrellPublished in: BMC neurology (2018)
(EudraCT reference) 2012-00418321 registered: 25/01/13. ISRCTN Registry: ISRCTN38687869 .